The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial

Ähnliche Einträge

• Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes - insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
  von: Cornel, Jan Hein, et al.
  Veröffentlicht: (2012)
• Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial
  von: Mahaffey, Kenneth, et al.
  Veröffentlicht: (2014)
• Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet inhibition and Patient Outcomes [PLATO] pulmonary function substudy)
  von: Storey, Robert, et al.
  Veröffentlicht: (2011)
• The incidence of bradyarrhythmias and clinical bradyarrhythmic events in patients with acute coronary syndromes treated with ticagrelor or clopidogrel in the PLATO (Platelet inhibition and patient outcomes) trial: results of the continuous electrocardiographic assessment substudy
  von: Scirica, Benjamin M., et al.
  Veröffentlicht: (2011)
• ST-elevation acute coronary syndromes in the Platelet Inhibition and Patient Outcomes (PLATO) trial: insights from the ECG substudy
  von: Armstrong, Paul W., et al.
  Veröffentlicht: (2012)